| Current Price | $66.31 | Mkt Cap | $2.9B |
|---|---|---|---|
| Open | $66.67 | P/E Ratio | 0.00 |
| Prev. Close | $65.27 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $65.24 - $67.61 | Volume | 397,249 |
| 52-Wk Range | $23.17 - $67.61 | Avg. Daily Vol. | 393,211 |
The Company develops, manufactures and sells innovative surgical devices designed to create precise lesions, or scars, in cardiac and soft tissues.
| Current Price | $66.31 | Mkt Cap | $2.9B |
|---|---|---|---|
| Open | $66.67 | P/E Ratio | 0.00 |
| Prev. Close | $65.27 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $65.24 - $67.61 | Volume | 397,249 |
| 52-Wk Range | $23.17 - $67.61 | Avg. Daily Vol. | 393,211 |
The best Bull and Bear pitches based on recency and number of recommendations.
Sometimes, you just take a small position in a long shot ... and ride it out. I think AtriCure may have turned the corner. Still a long shot ... but no longer a crap shoot.
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about ATRC.
Recs
Turtlebale
(42.86)
Submitted: 8/26/2016 2:37:46 PM :
Start Price:
$14.70
NASDAQ:ATRC Score:
+271.16
growing markets
Recs
TripleTheMarket
(23.54)
Submitted: 6/2/2011 1:05:41 PM :
Start Price:
$14.45
NASDAQ:ATRC Score:
+163.08
Momentum!
Recs
dstnewman
(95.39)
Submitted: 2/23/2008 3:23:31 PM :
Start Price:
$11.95
NASDAQ:ATRC Score:
+255.34
Strongly considering adding this to my real portfolio when I get a little more cash to invest.
New company just came public back in 2006. The have had consistant growth ever since. One of the biggest attractions that I have to the company is the fact that a large portion of it's income is from procedures that are not officially FDA approved. It is working towards approval, at which point it can start marketing it specifically for that cause. Margins are very good and Y-O-Y growth looks quite interesting. It is still a couple years from being profitable though, which makes it very speculative, but it has multiple FDA trials that are scheduled to be completed this year (08), which means that there are a LOT of catalysts for growth.
Find the members with the highest scoring picks in ATRC.
Buckless1120 (< 20) Score: +1,247.17
The Score Leader is the player with the highest score across all their picks in ATRC.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| Buckless1120 | < 20 | 11/3/2008 |
|
1Y | $4.00 | +1,557.75% | +310.58% | +1,247.17 | 0 Comment | |
| invest4321 | 63.89 | 8/10/2010 |
|
5Y | $6.80 | +875.15% | +247.93% | +627.21 | 0 Comment | |
| bashstocks | 48.31 | 3/4/2013 |
|
1Y | $8.50 | +680.12% | +156.71% | +523.41 | 0 Comment | |
| pkhann1 | < 20 | 2/14/2013 |
|
1Y | $8.54 | +676.46% | +155.86% | +520.60 | 0 Comment | |
| BeachWeb67 | < 20 | 11/11/2010 |
|
5Y | $8.10 | +718.64% | +221.83% | +496.81 | 0 Comment | |
| n2camo | 49.19 | 8/14/2013 |
|
3M | $9.39 | +606.18% | +129.80% | +476.38 | 0 Comment | |
| looktroyson | 54.11 | 6/25/2013 |
|
5Y | $9.25 | +616.86% | +146.21% | +470.65 | 0 Comment | |
| sonytechrep | < 20 | 12/8/2006 |
|
3W | $9.45 | +601.69% | +193.06% | +408.64 | 0 Comment | |
| RayCool | 79.18 | 11/28/2006 |
|
3W | $9.50 | +598.00% | +198.58% | +399.42 | 0 Comment | |
| AlCzervik1980 | 63.22 | 6/13/2007 |
|
NS | $10.10 | +556.53% | +172.31% | +384.22 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
